Reviewed,
UniProtKB/Swiss-Prot P61978 (HNRPK_HUMAN)
Last modified
September 23, 2008.
Version 73.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Heterogeneous nuclear ribonucleoprotein K Short name=hnRNP K Alternative name(s): Transformation up-regulated nuclear protein Short name=TUNP | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 463 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | One of the major pre-mRNA-binding proteins. Binds tenaciously to poly(C) sequences. Likely to play a role in the nuclear metabolism of hnRNAs, particularly for pre-mRNAs that contain cytidine-rich sequences. Can also bind poly(C) single-stranded DNA. |
| Subunit structure | Interacts with ZIK1 By similarity. Identified in the spliceosome C complex, at least composed of AQR, ASCC3L1, C19orf29, CDC40, CDC5L, CRNKL1, DDX23, DDX41, DDX48, DDX5, DGCR14, DHX35, DHX38, DHX8, EFTUD2, FRG1, GPATC1, HNRPA1, HNRPA2B1, HNRPA3, HNRPC, HNRPF, HNRPH1, HNRNPK, HNRPM, HNRPR, HNRPU, KIAA1160, KIAA1604, LSM2, LSM3, MAGOH, MORG1, PABPC1, PLRG1, PNN, PPIE, PPIL1, PPIL3, PPWD1, PRPF19, PRPF4B, PRPF6, PRPF8, RALY, RBM22, RBM8A, RBMX, SART1, SF3A1, SF3A2, SF3A3, SF3B1, SF3B2, SF3B3, SFRS1, SKIV2L2, SNRPA1, SNRPB, SNRPB2, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF, SNRPG, SNW1, SRRM1, SRRM2, SYF2, SYNCRIP, TFIP11, THOC4, U2AF1, WDR57, XAB2 and ZCCHC8. Interacts with HCV core protein. Interacts with ANKRD28. |
| Subcellular location | |
| Post-translational modification | Arg-296 and Arg-299 are dimethylated, probably to asymmetric dimethylarginine. |
| Sequence similarities | Contains 3 KH domains. |
| Mass spectrometry | Molecular weight is 50976.25 Da from positions 1 - 463 (P61978-1). Determined by MALDI. Ref.10 |
Ontologies
Keywords | |
|---|---|
| Biological process | Host-virus interaction mRNA processing mRNA splicing |
| Cellular component | Cytoplasm Nucleus Spliceosome |
| Coding sequence diversity | Alternative splicing |
| Domain | Repeat |
| Ligand | DNA-binding RNA-binding |
| Molecular function | Ribonucleoprotein |
| PTM | Acetylation Methylation Phosphoprotein |
| Technical term | 3D-structure Direct protein sequencing |
Gene Ontology (GO) | |
| Biological process | nuclear mRNA splicing, via spliceosome Inferred from Experiment. Source: Reactome signal transductionTraceable author statement. Source: ProtInc |
| Cellular component | cytoplasm Traceable author statement. Source: ProtInc heterogeneous nuclear ribonucleoprotein complex Ref.2Traceable author statement. Source: ProtInc nucleoplasm Ref.1Traceable author statement. Source: ProtInc |
| Molecular function | RNA binding Ref.2 Traceable author statement. Source: ProtInc protein bindingInferred from physical interaction. Source: IntAct |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| HCK | P08631 | 1 | EBI-304185,EBI-346340 | |
| QKI | Q96PU8 | 1 | EBI-304185,EBI-945792 |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | |||||
| Isoform 1 (identifier: P61978-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | |||||
| Isoform 2 (identifier: P61978-2) The sequence of this isoform differs from the canonical sequence as follows: 459-463: SGKFF → ADVEGF | |||||
| Isoform 3 (identifier: P61978-3) The sequence of this isoform differs from the canonical sequence as follows: 111-134: Missing. 459-463: SGKFF → ADVEGF | |||||
| Notes: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | |||||||||||||||||
Molecule processing | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 463 | 463 | Heterogeneous nuclear ribonucleoprotein K | ||||||||||||||||||
Regions | |||||||||||||||||||||
| Domain | 42 – 104 | 63 | KH 1 | ||||||||||||||||||
| Repeat | 54 – 76 | 23 | 1-1 | ||||||||||||||||||
| Repeat | 59 – 62 | 4 | 3-1 | ||||||||||||||||||
| Domain | 144 – 209 | 66 | KH 2 | ||||||||||||||||||
| Repeat | 245 – 250 | 6 | 2-1 | ||||||||||||||||||
| Repeat | 257 – 260 | 4 | 3-2 | ||||||||||||||||||
| Repeat | 267 – 270 | 4 | 3-3 | ||||||||||||||||||
| Repeat | 295 – 298 | 4 | 3-4 | ||||||||||||||||||
| Repeat | 324 – 329 | 6 | 2-2 | ||||||||||||||||||
| Domain | 387 – 451 | 65 | KH 3 | ||||||||||||||||||
| Repeat | 399 – 421 | 23 | 1-2 | ||||||||||||||||||
| Repeat | 404 – 407 | 4 | 3-5 | ||||||||||||||||||
| Region | 54 – 421 | 368 | 2 X 22 AA approximate repeats | ||||||||||||||||||
| Region | 59 – 407 | 349 | 5 X 4 AA repeats of G-X-G-G | ||||||||||||||||||
| Region | 209 – 337 | 129 | Interaction with ZIK1 By similarity | ||||||||||||||||||
| Region | 236 – 273 | 38 | RNA-binding RGG-box | ||||||||||||||||||
| Region | 245 – 329 | 85 | 2 X 6 AA approximate repeats | ||||||||||||||||||
| Compositional bias | 289 – 294 | 6 | Poly-Pro | ||||||||||||||||||
| Compositional bias | 310 – 315 | 6 | Poly-Pro | ||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||
| Modified residue | 1 | 1 | N-acetylmethionine | ||||||||||||||||||
| Modified residue | 3 | 1 | Phosphothreonine | ||||||||||||||||||
| Modified residue | 36 | 1 | Phosphoserine | ||||||||||||||||||
| Modified residue | 116 | 1 | Phosphoserine | ||||||||||||||||||
| Modified residue | 214 | 1 | Phosphoserine | ||||||||||||||||||
| Modified residue | 216 | 1 | Phosphoserine | ||||||||||||||||||
| Modified residue | 284 | 1 | Phosphoserine | ||||||||||||||||||
| Modified residue | 296 | 1 | Omega-N-methylated arginine | ||||||||||||||||||
| Modified residue | 299 | 1 | Omega-N-methylated arginine | ||||||||||||||||||
| Modified residue | 379 | 1 | Phosphoserine | ||||||||||||||||||
Natural variations | |||||||||||||||||||||
| Alternative sequence | 111 – 134 | 24 | Missing in isoform 3. | ||||||||||||||||||
| Alternative sequence | 459 – 463 | 5 | SGKFF → ADVEGF in isoform 2 and isoform 3. | ||||||||||||||||||
Experimental info | |||||||||||||||||||||
| Sequence conflict | 32 | 1 | A → D in CAA51267. Ref.2 | ||||||||||||||||||
Secondary structure | |||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||
| Beta strand | 388 – 395 | 8 | |||||||||||||||||||
| Turn | 396 – 398 | 3 | |||||||||||||||||||
| Helix | 399 – 402 | 4 | |||||||||||||||||||
| Helix | 405 – 407 | 3 | |||||||||||||||||||
| Helix | 408 – 417 | 10 | |||||||||||||||||||
| Beta strand | 420 – 423 | 4 | |||||||||||||||||||
| Beta strand | 430 – 439 | 10 | |||||||||||||||||||
| Helix | 441 – 459 | 19 | |||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Characterization and primary structure of the poly(C)-binding heterogeneous nuclear ribonucleoprotein complex K protein." Matunis M.J., Michael W.M., Dreyfuss G. Mol. Cell. Biol. 12:164-171(1992) [PubMed: 1729596] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION. |
| [2] | "Identification, molecular cloning, expression and chromosome mapping of a family of transformation upregulated hnRNP-K proteins derived by alternative splicing." Dejgaard K., Leffers H., Rasmussen H.H., Madsen P., Kruse T.A., Gesser B., Nielsen H., Celis J.E. J. Mol. Biol. 236:33-48(1994) [PubMed: 8107114] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PHOSPHORYLATION. |
| [3] | Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S., Ohara O., Nagase T., Kikuno R.F. Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). Tissue: Brain. |
| [4] | "DNA sequence and analysis of human chromosome 9." Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S., Bagguley C.L. Dunham I.Nature 429:369-374(2004) [PubMed: 15164053] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). Tissue: Muscle. |
| [7] | Bienvenut W.V., Vousden K.H., Lukashchuk N. Submitted (MAR-2008) to UniProtKB Cited for: PROTEIN SEQUENCE OF 1-52; 70-103; 149-163; 192-201; 208-219; 317-325; 378-405 AND 423-456, ACETYLATION AT MET-1, MASS SPECTROMETRY. Tissue: Lung carcinoma. |
| [8] | Lubec G., Afjehi-Sadat L. Submitted (MAR-2007) to UniProtKB Cited for: PROTEIN SEQUENCE OF 149-163, MASS SPECTROMETRY. Tissue: Brain and Cajal-Retzius cell. |
| [9] | "Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein K." Hsieh T.-Y., Matsumoto M., Chou H.-C., Schneider R., Hwang S.B., Lee A.S., Lai M.M.C. J. Biol. Chem. 273:17651-17659(1998) [PubMed: 9651361] [Abstract] Cited for: INTERACTION WITH HCV CORE PROTEIN. |
| [10] | "Cluster analysis of an extensive human breast cancer cell line protein expression map database." Harris R.A., Yang A., Stein R.C., Lucy K., Brusten L., Herath A., Parekh R., Waterfield M.D., O'Hare M.J., Neville M.A., Page M.J., Zvelebil M.J. Proteomics 2:212-223(2002) [PubMed: 11840567] [Abstract] Cited for: MASS SPECTROMETRY. Tissue: Mammary cancer. |
| [11] | "Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis." Jurica M.S., Licklider L.J., Gygi S.P., Grigorieff N., Moore M.J. RNA 8:426-439(2002) [PubMed: 11991638] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN THE SPICEOSOMAL C COMPLEX. |
| [12] | "Global phosphoproteome of HT-29 human colon adenocarcinoma cells." Kim J.-E., Tannenbaum S.R., White F.M. J. Proteome Res. 4:1339-1346(2005) [PubMed: 16083285] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-284, MASS SPECTROMETRY. |
| [13] | "PITK, a PP1 targeting subunit that modulates the phosphorylation of the transcriptional regulator hnRNP K." Kwiek N.C., Thacker D.F., Datto M.B., Megosh H.B., Haystead T.A.J. Cell. Signal. 18:1769-1778(2006) [PubMed: 16564677] [Abstract] Cited for: INTERACTION WITH ANKRD28, PHOSPHORYLATION AT SER-284. |
| [14] | "Identifying and quantifying in vivo methylation sites by heavy methyl SILAC." Ong S.E., Mittler G., Mann M. Nat. Methods 1:119-126(2004) [PubMed: 15782174] [Abstract] Cited for: METHYLATION [LARGE SCALE ANALYSIS] AT ARG-296 AND ARG-299, MASS SPECTROMETRY. |
| [15] | "Large-scale characterization of HeLa cell nuclear phosphoproteins." Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-3; SER-116 AND SER-284, MASS SPECTROMETRY. Tissue: Epithelium. |
| [16] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36; SER-216 AND SER-284, MASS SPECTROMETRY. Tissue: Epithelium. |
| [17] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed: 16964243] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216; SER-284 AND SER-379, MASS SPECTROMETRY. Tissue: Epithelium. |
| [18] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed: 17924679] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-214; SER-216 AND SER-379, MASS SPECTROMETRY. Tissue: Epithelium. |
| [19] | "Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry." Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A. Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007) [PubMed: 17287340] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-116 AND SER-284, MASS SPECTROMETRY. |
| [20] | "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calci |

Clusters with